Fresenius SE 1Q Sales Fell; Backs 2021 Guidance
May 06 2021 - 1:54AM
Dow Jones News
By Kim Richters
Fresenius SE said sales and adjusted profit in the first quarter
declined, and the German healthcare company backed its full-year
2021 guidance.
Quarterly net profit before special items was 435 million euros
($522.2 million), down from EUR465 million a year earlier. Sales
declined to EUR9.0 billion from EUR9.1 billion, the company
said.
At Fresenius Medical Care, the company's dialysis division, net
profit fell to EUR249 million from EUR283 million, while sales fell
to EUR4.21 billion from EUR4.49 billion, the company said.
Fresenius SE backed its guidance for 2021, expecting low- to
mid-single-digit percentage sales growth from EUR36.28 billion in
2020. Net profit before special items for the year is expected to
be at least broadly stable compared with the prior year's EUR1.80
billion. Both outlooks are in constant currency, the company
said.
The company said that it would start cost-saving and efficiency
measures and that the coronavirus pandemic continues to affect its
operations this year.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
May 06, 2021 01:39 ET (05:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
From Sep 2023 to Sep 2024